NCT00131755|CompletedPhase 4
Efficacy of Diazoxide in Type 1 Diabetes
Efficacy of 6 Months Treatment With Diazoxide at Bedtime in Preventing Beta-cell Demise in Newly Diagnosed Type 1 Diabetes
Loading search results
Efficacy of 6 Months Treatment With Diazoxide at Bedtime in Preventing Beta-cell Demise in Newly Diagnosed Type 1 Diabetes
Sponsor study identifier
Secondary identifiers
interventional
40
1 country
1
Study Start
February 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2008
Actual (reported)Study Completion
August 2008
Actual (reported)The purpose of this study is to find out if Diazoxide can partly retain insulin production in newly diagnosed type 1 diabetes patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2008
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2005
Date type not reportedThis date has not been verified as actual or estimated.
August 17, 2005
Actual (reported)August 19, 2005
Actual (reported)August 2008
Actual (reported)August 2008
Actual (reported)Insulin secretion (measured by fasting and stimulated c-peptide)
12 months
Glycemic control (measured by blood glucose)
12 months
Autoimmune activity (measured by islet antibodies)
6 months
Side effects
12 months
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University Hospital of Trondheim
Trondheim, 7006, Norway
Grill Valdemar, MD PhD
Norwegian University of Science and Technology
40 participants (actual enrollment reported by the registry).
First Submitted
August 17, 2005
First Posted
August 19, 2005
Study Start
February 2005
Date type not reportedThis date has not been verified as actual or estimated.
Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
Contact the study team to confirm eligibility.
Primary Completion
August 2008
Actual (reported)Study Completion
August 2008
Actual (reported)Last Updated
July 18, 2011
Record last verified: 2011-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: